Article
Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients.
Breast cancer research and treatment - 1 Dec 2004
Tarnowski B, Chudecka-Głaz A, Górski B, Rzepka-Górska I
Abstract excerpt
The aim of the study was to compare VEGF serum levels in breast cancer patients with and without BRCA1 gene mutation. We enrolled 80 patients, 22 premenopausal and 58 postmenopausal. We found statistically significant lower levels of VEGF in patients with BRCA1 gene mutation as compared with breast cancer patients without this mutation.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
